ATP13A3 silencing also sensitized MYCN‐amplified (KELLY) and non‐MYCN‐amplified (SH‐SY5Y) neuroblastoma cells to escalating DFMO concentrations, which resulted in reduced growth and colony‐forming capabilities (Fig. 7E–H). The gene discussed is MYCN; the disease is neuroblastoma.